Resistance training
Behavioralresistance training consists of lower and upper extremities exercises. We focus on biceps and hamstring to be trained. One session was held for around 30 minutes.
NCT Number: NCT02674659
This research add resistance training to patients who undergo cardiac rehabilitation program after coronary bypass surgery, comparing the level of PCSK9 level on that group to another group who receives conventional rehabilitation program (only aerobic exercise)
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
The PCSK9 level measured before and after cardiac rehabilitation program (around 3-4 weeks), and compared between two groups. ELISA method will be used to measure plasma PCSK9 level.
Resistance training will be given by professional trainer in gymnasium of National Cardiovascular Center Harapan Kita supervised by cardiologists, following rules from American College of Sports Medicine guideline regarding to exercise after cardiac event.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
resistance training consists of lower and upper extremities exercises. We focus on biceps and hamstring to be trained. One session was held for around 30 minutes.
aerobic exercise consists of warming up session, treadmill exercise (around 20-30 minutes), and wrap-up session (for all session about 1 hour)
Time frame: 3-4 weeks (after completion of 12 sessions of cardiac rehabilitation program)
this outcome measurement will be achieved by taking patient's blood sample after cardiac rehabilitation program. The method that we use to check PCSK-9 level is ELISA method
Time frame: 3-4 weeks (after completion of 12 sessions of cardiac rehabilitation program)
this outcome measurement will be achieved by taking patient's blood sample after cardiac rehabilitation program
Time frame: 3-4 weeks (after completion of 12 sessions of cardiac rehabilitation program)
Body Mass Index is calculated by calculating the measured body weight divided by the height square in measure. We take BMI data after cardiac rehabilitation program in every participant.
Time frame: 3-4 weeks (after completion of 12 sessions of cardiac rehabilitation program)
this outcome measurement will be achieved by taking patient's blood sample after cardiac rehabilitation program
Time frame: 3-4 weeks (after completion of 12 sessions of cardiac rehabilitation program)
this outcome measurement will be achieved by taking patient's blood sample after cardiac rehabilitation program
Time frame: 3-4 weeks (after completion of 12 sessions of cardiac rehabilitation program)
This outcome measurement will be achieved by taking the patient's blood sample after cardiac rehabilitation program
Time frame: 3-4 weeks (after completion of 12 sessions of cardiac rehabilitation program)
Blood glucose concentration was taken after 10-12-hour fasting. This outcome measurement will be achieved by taking the patient's blood sample after cardiac rehabilitation program
Time frame: 3-4 weeks (after completion of 12 sessions of cardiac rehabilitation program)
this outcome measurement will be achieved by taking the patient's blood pressure after cardiac rehabilitation program
Time frame: 3-4 weeks (after completion of 12 sessions of cardiac rehabilitation program)
this outcome measurement will be achieved by taking the patient's blood pressure after cardiac rehabilitation program
National Cardiovascular Center Harapan Kita Hospital Indonesia
Other
The Effect of Resistance Training on Proprotein Subtilisin Convertase Kexin 9 (PCSK-9) Level in Patients After Coronary Bypass Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07612774
Acute Coronary Syndrome, Arterial Occlusive Diseases
Chengdu, Sichuan, China
View Trial DetailsNCT07468955
Arterial Occlusive Diseases, Arteriosclerosis
Kütahya, Center, Turkey (Türkiye)
View Trial DetailsNCT06029517
Arterial Occlusive Diseases, Arteriosclerosis
Buffalo, New York, United States
View Trial DetailsNCT04058990
Arterial Occlusive Diseases, Arteriosclerosis
Kitakyushu, Fukuoka, Japan
View Trial Details